EP4780327A2 - Entscheidungsunterstützung für einen glucose-keton-sensor - Google Patents

Entscheidungsunterstützung für einen glucose-keton-sensor

Info

Publication number
EP4780327A2
EP4780327A2 EP24787600.6A EP24787600A EP4780327A2 EP 4780327 A2 EP4780327 A2 EP 4780327A2 EP 24787600 A EP24787600 A EP 24787600A EP 4780327 A2 EP4780327 A2 EP 4780327A2
Authority
EP
European Patent Office
Prior art keywords
analyte
ketone
level
aspects
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24787600.6A
Other languages
English (en)
French (fr)
Inventor
Gary A. Hayter
Erwin S. Budiman
Marc B. Taub
Wesley Scott Harper
Timothy C. Dunn
Vincent M. Dipalma
Edward J. KUPA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of EP4780327A2 publication Critical patent/EP4780327A2/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Artificial Intelligence (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Evolutionary Computation (AREA)
  • Fuzzy Systems (AREA)
  • Mathematical Physics (AREA)
  • Nutrition Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP24787600.6A 2023-09-22 2024-09-20 Entscheidungsunterstützung für einen glucose-keton-sensor Pending EP4780327A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363539927P 2023-09-22 2023-09-22
US202463696713P 2024-09-19 2024-09-19
PCT/US2024/047778 WO2025064882A2 (en) 2023-09-22 2024-09-20 Decision support for glucose-ketone sensor

Publications (1)

Publication Number Publication Date
EP4780327A2 true EP4780327A2 (de) 2026-07-29

Family

ID=93061808

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24787600.6A Pending EP4780327A2 (de) 2023-09-22 2024-09-20 Entscheidungsunterstützung für einen glucose-keton-sensor

Country Status (6)

Country Link
EP (1) EP4780327A2 (de)
KR (1) KR20260069729A (de)
CN (1) CN121843651A (de)
AU (1) AU2024343861A1 (de)
MX (1) MX2026003038A (de)
WO (1) WO2025064882A2 (de)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4325222A3 (de) 2016-03-04 2024-05-01 Abbott Diabetes Care Inc. Nad(p)-abhängige reagierende enzyme, elektroden und sensoren sowie verfahren zur herstellung und verwendung davon
US20200101286A1 (en) * 2016-05-15 2020-04-02 Biolinq, Inc. Devices And Methods For The Generation Of Alerts Due To Rising Levels Of Circulating Ketone Bodies In Physiological Fluids
LT3592213T (lt) 2017-03-08 2023-06-12 Abbott Diabetes Care Inc. Sveikatos ir mitybos stebėjimo ir valdymo sistema, naudojant analitės duomenis
AU2020214230B2 (en) 2019-01-28 2023-03-02 Abbott Diabetes Care Inc. Analyte sensors employing multiple enzymes and methods associated therewith
EP4574038A3 (de) 2019-01-28 2025-08-27 Abbott Diabetes Care, Inc. Analytsensoren und messverfahren mit dualem nachweis von glucose und ketonen
JP7522196B2 (ja) 2019-12-23 2024-07-24 アボット ダイアベティス ケア インコーポレイテッド 低電位検出を特徴とする被検物質センサおよび検知方法
JP7590439B2 (ja) 2020-01-03 2024-11-26 アボット ダイアベティス ケア インコーポレイテッド 複数被検物質を検出するためのセンサアレイシステムおよび方法
WO2021178307A1 (en) * 2020-03-02 2021-09-10 Dexcom, Inc. Evaluation of data to provide decision support for a ketogenic lifestyle
JP7837647B2 (ja) * 2020-06-08 2026-03-31 アボット ダイアベティス ケア インコーポレイテッド 改善された検体センサー精度及び故障検出のためのシステム、装置、及び方法
CN116018084A (zh) * 2020-09-18 2023-04-25 美敦力迷你迈德公司 酮体感测装置和方法
EP4258991A1 (de) 2020-12-10 2023-10-18 Abbott Diabetes Care, Inc. Analytsensoren zur messung von ketonen und verfahren zur verwendung davon
CN122182027A (zh) 2020-12-15 2026-06-12 美国雅培糖尿病护理公司 基于nad(p)-依赖酶的传感器的nad(p)储库
WO2022147506A1 (en) 2020-12-31 2022-07-07 Abbott Diabetes Care Inc. Analyte sensors and methods of use thereof
AU2022212954B2 (en) 2021-01-26 2025-04-24 Abbott Diabetes Care Inc. Systems, devices, and methods related to ketone sensors
CA3230906A1 (en) * 2021-09-15 2023-03-23 Abbott Diabetes Care Inc. Systems, devices, and methods for applications for communication with ketone sensors
JP2024542916A (ja) * 2021-11-04 2024-11-19 デックスコム・インコーポレーテッド 連続的に監視された分析物データを使用して糖尿病意思決定支援を提供するための感知システム及び方法
EP4562647A1 (de) 2022-07-27 2025-06-04 Abbott Diabetes Care Inc. Systeme und verfahren zur diabetesverwaltung

Also Published As

Publication number Publication date
MX2026003038A (es) 2026-05-04
WO2025064882A3 (en) 2025-05-15
AU2024343861A1 (en) 2026-01-22
CN121843651A (zh) 2026-04-10
WO2025064882A2 (en) 2025-03-27
KR20260069729A (ko) 2026-05-15

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20260319

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR